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Dear Editor,
In the previous issue of Radiologia Brasileira, Ferreira et 
al.(1) described the main indications for breast magnetic reso-
nance imaging (MRI) examination at a referral center for the 
diagnosis and treatment of breast cancer in Brazil. The results 
presented by those authors corroborate the findings of a previ-
ous study conducted by our group, carried out at another re-
ferral center in Brazil and published in the journal in 2011(2). 
Although they were performed at facilities in different states and 
in different time periods (2014–2018 and 2008–2009, respec-
tively), both studies showed that most breast MRI examinations 
performed in Brazil are requested for the evaluation of patients 
in whom the mammography and ultrasound findings are incon-
clusive. Although some studies have shown the benefit of MRI 
in some specific situations within that context(3,4), that indica-
tion has little foundation in the literature and even in the Breast 
Imaging Reporting and Data System recommendations(5). Other 
indications that are more well-established in the literature(6–8), 
such as screening for high-risk patients, locoregional staging, 
and assessment of the response to neoadjuvant treatment, ac-
count for a lower proportion of the MRI examinations requested.
Both of the studies cited above were carried out at referral 
centers for cancer, which suggests that their findings cannot be 
extrapolated to all facilities in Brazil. However, the factors re-
lated to those findings merit further discussion. Unfortunately, 
the high cost and limited availability of breast MRI are still im-
portant limiting factors for the dissemination of the method in 
the country. Although breast MRI is already a well-established 
method, there are few facilities in Brazil where this examination 
is performed by trained professionals, which also impedes the 
dissemination of the method and even results in a lack of confi-
dence on the part of the requesting physicians. There are even 
fewer facilities that perform imaging-guided biopsy of suspicious 
lesions that are detected on MRI and have not been identified 
by other methods (mammography and ultrasound), which makes 
the management of such lesions more difficult in some cases.
Updating the data from our previous study(2), we observed 
that, among the 1,837 breast MRI examinations performed at 
our center between February 2019 and February 2020 (prior to 
the current pandemic), the main indications were as follows: di-
agnostic uncertainty after mammography or ultrasound, in 490 
cases (26.7%); surveillance after breast cancer treatment, in 423 
cases (23.0%); staging, in 255 cases (13.9%); screening of high-
risk patients, in 226 cases (12.3%); and assessment of the re-
sponse to neoadjuvant chemotherapy, in 145 cases (7.9%). These 
data suggest a change in the profile of the tests requested over 
time, with a reduction in indications due to equivocal findings 
and a proportional increase in other indications. Therefore, we 
believe that better training and supervision at facilities that per-
form breast MRI, as well as greater dissemination and discussion 
of the most appropriate indications for the method among re-
questing physicians, can favor the optimized use of this resource, 
making it more cost-effective, in Brazil.
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Indications for breast magnetic resonance imaging in Brazil: 
past, present, and future
Portal vein embolization, biembolization, and liver venous 
deprivation
Dear editor
We read with great interest the article “Liver venous depri-
vation prior to hepatectomy: an interventional radiology proce-
dure”, authored by Alves et al.(1), in a recent issue of Radiologia 
Brasileira. This is an excellent addition to the “Advances in Radi-
ology” section of the journal, which highlights the latest develop-
ments in medical practice in Brazil. Liver regeneration prior to 
major hepatectomy is decisive in cancer management because it 
allows these potentially curative surgical procedures to be per-
formed in otherwise inoperable patients, thus improving survival 
outcomes(2). Portal vein embolization (PVE), used for decades as 
a method of inducing liver hypertrophy(3), has recently been used 
in combination with embolization of one or more hepatic veins(4).
Alves et al.(1) described concomitant PVE and proximal right 
hepatic vein embolization with a vascular plug. This technique 
might be more appropriately designated biembolization(5), be-
ing slightly different from liver venous deprivation (LVD). The 
LVD procedure has been described as: PVE plus proximal and 
distal embolization of the hepatic veins. Proximal embolization 
of the hepatic vein is accomplished with a vascular plug, as in 
biembolization, whereas distal embolization of the hepatic vein 
is achieved with N-butyl-cyanoacrylate (NBCA) plus lipiodol, as 
in LVD(2). Why might this be relevant? Invariably, venovenous 
collaterals between liver segments V/VIII and IV are present(6) 
and will increase in size after plug deployment(4). Distal emboliza-
tion with a liquid embolic agent (i.e., NBCA) not only eliminates 
flow in the target vein but also occludes those collaterals, which 
might have benefits in terms of liver hypertrophy induction. In 
addition, biembolization and LVD may require different techni-
cal approaches: LVD is usually performed through a percutane-
ous trans-hepatic approach(4,7), making it easier to inject liquid 
embolic agents after plug deployment, whereas biembolization is 
performed through a transjugular approach (Figure 1).
Segment IV PVE, which was performed by Alves et al.(1), 
has been reported to induce additional liver hypertrophy(8). 
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However, segment IV embolization is controversial: the seg-
ment IV portal branches are usually numerous and tiny, which 
increases the procedure time and the degree of technical dif-
ficulty; liquid embolic agents are trickier to use, because any 
reflux would cause nontarget embolization of liver segments II 
and III; due to the degree of technical difficulty, suboptimal em-
bolization of segment IV might be an issue(9); and segment IV 
is the main territory for systemic-portal venous shunts, possibly 
decreasing the efficacy of the procedure(10). To overcome the 
limitations of PVE of segment IV, a more aggressive form of LVD 
has been proposed—extended LVD(11)—which consists of LVD 
plus middle hepatic vein embolization. Extended LVD has been 
shown to be safe and highly effective, promoting an unparal-
leled 53.4% increase in liver volume within only seven days(11).
Future studies focusing on patient selection are needed. 
When and how to choose from such a variety of interventional 
tools? How to best predict post-hepatectomy liver failure? How 
can we choose between volumetric computed tomography and liver 
function studies (e.g., 99mTc-mebrofenin hepatobiliary scintigra-
phy, gadoxetic acid-enhanced magnetic resonance imaging, and 
indocyanine green retention test)—or should we perform both? 
Most importantly, when is the liver ready for major surgery? How 
can we safely accelerate this preoperative process? Answering such 
questions are the reason for having multidisciplinary team meet-
ings that allow personalized medical care, with input from differ-
ent medical perspectives. We want to congratulate the authors not 
only for obtaining a regenerative outcome that allowed successful 
major hepatectomy within 41 days after embolization but also for 
highlighting the potential role and advantages of LVD versus PVE, 
providing grounds to expand future studies in this field(12).
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Figure 1. Fluoroscopic image (1A) obtained immediately after LVD and contrast-
enhanced coronal CT (1B) obtained 14 days after LVD. Note the vascular plug 
(red arrows) placed in the right hepatic vein for proximal embolization and 
NBCA plus lipiodol occluding the distal branches (yellow arrows). Note also 
NBCA plus lipiodol occluding a venovenous collateral (green arrows) and right 
portal vein embolization with NBCA plus lipiodol (white arrow).
http://dx.doi.org/10.1590/0100-3984.2021.0040
Reply
We received with great enthusiasm the Letter to the Edi-
tor “Portal vein embolization, biembolization, and liver venous 
deprivation”, authored by Dr. Luz and Dr. Bilhim. We certainly 
agree that the precise nomenclature for the procedure described 
in our paper should be “Portal vein embolization with hepatic 
vein biembolization”. The added technique of distal embolization 
of the hepatic veins, described in liver venous deprivation, would 
likely represent further liver hypertrophy and probably better he-
patic functionality than those achieved in the case we described. 
Our group has now standardized liver venous deprivation with a 
transhepatic approach as the technique of choice in such cases. 
In regard to the issue of hepatic segment IV embolization, we 
are of the same opinion (that it presents a technical challenge 
to the PVE procedure), and extended LVD with middle hepatic 
vein, rather than segment IV embolization, is now the preferred 
method in our department. Nevertheless, the theme of combined 
PVE and LVD (or biembolization) raises multiple questions and 
concerns, which will likely be addressed by prospective multi-
center studies and collaborative multidisciplinary discussions 
to optimize medical care for the affected patients. We want to 
thank the authors for their interest in our paper, as well as for 
the perfectly highlighted issues, which further elevate the level of 
scientific debate in the area of interventional radiology.
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